vaccine but not by an experimental aceliular pertussis vaccine. Since the Bordetella GroEL-like protein was found to contain epitopes similar to those on the mammalian analog, the potential exists that vaccination with standard DTP vaccines may induce antibodies which react with the mammalian GroEL analog.
Recently, a family of related proteins has been identified in many species of bacteria as well as in the mitochondria and chloroplasts of eucaryotes (17, 23, 34, 35) . The prototype of this family is the GroEL protein of Escherichia coli, which is a tetradecamer of subunits, each subunit having a molecular weight of about 65,000 (18, 22) . GroEL consists of two seven-member rings of subunits stacked together. The biochemical role of GroEL has recently been elucidated. This protein has been identified as a molecular chaperone which aids in the proper folding and assembly of polypeptide chains, probably by binding to unfolded polypeptide chains, either as they are synthesized or very shortly thereafter, and thereby preventing the formation of incorrectly folded intermediates (13, 15, 31) .
Increased expression of GroEL and many other members of this family of proteins often occurs under conditions which promote denaturation of proteins such as high temperatures (11, 28) . Increased levels of GroEL-like proteins would prevent formation of denatured protein aggregates within the cell by inhibiting incorrect interactions that would cause the formation of these aggregates (13) .
The members of the GroEL family of proteins are potent immunogens in a number of infections including those caused by Mycobacterium tuberculosis, Mycobacterium leprae, and Chlamydia spp. (30, 35, 39) . These antigens have been postulated to be involved in the survival of the bacteria in the host (7), pathogenesis of the organism (30) , and induction of autoimmunity (38) .
Recently, antibodies to a 63-kDa protein of Bordetella pertussis were found in sera from patients diagnosed with culture-confirmed pertussis and in sera from children vaccinated with standard diphtheria-tetanus-pertussis (DTP) vaccine (2) . In the same study, this 63-kDa protein was found to react with an antibody elicited by the mycobacterial GroEL SDS-PAGE. SDS-PAGE was performed essentially as described by Laemmli (27) , using either 12 or 15% polyacrylamide gels.
Antibodies. Monoclonal antibody MLIIH9 (ascitic fluid), reactive with a mycobacterial GroEL-like protein (14) , was kindly provided by Thomas M. Buchanan (University of Washington, Seattle, Wash.) and was used at a dilution of 1:4,000. Anti-Pl serum, reactive with a GroEL-like mitochondrial protein of CHO cells (16) , was a gift of Radhey S. Gupta (McMaster University, Hamilton, Ontario, Canada) and was used at a dilution of 1: 1,000. A polyclonal antiserum which is reactive with a 57-kDa chlamydial GroEL-like protein (8, 9, 30) was generously provided by Richard P. Morrison (Rocky Mountain Laboratories, National Institutes of Health, Hamilton, Mont.) and was used at a dilution of 1:1,000.
Immunization procedures. BALB/c mice were immunized twice, intraperitoneally, with 0.5 ml of DTP vaccine (adsorbed), U.S. Standard Pertussis Vaccine (lot 9) (nonadsorbed), JNIH-6 (1), or 8 [ig of purified B. pertussis GroELlike protein adsorbed onto an equivalent weight of Alhydrogel (Superfos a/s, Vedbaek, Denmark), at a 4-week interval. Mice were bled 2 weeks after the second immunization, and sera were prepared. For immunoblot analysis, the, sera were utilized at a 1:100 dilution unless otherwise indicated.
Immunoblot analysis. Antigens which had been subjected to SDS-PAGE were electrophoretically transferred to nitrocellulose sheets (pore size, 0.45 ,um; Schleicher & Schuell, Keene, N.H.) at 100 V for 1 h in a solution consisting of 25 mM Tris, 192 mM glycine, and 5% (vol/vol) methanol. The nitrocellulose sheets were incubated overnight with 10% (wt/vol) skim milk in distilled water. Nitrocellulose strips were washed three times with phosphate-buffered saline, pH 7.4, containing 0.2% gelatin (PBS-gelatin) and were incubated with the corresponding serum or monoclonal antibody diluted in PBS-gelatin. After three additional washes with PBS-gelatin, the strips were incubated for 1 h with either anti-mouse or anti-rabbit antibody conjugated to horseradish peroxidase (Bio-Rad Laboratories, Richmond, Calif.). The nitrocellulose strips were washed with PBS, and the bands were visualized by the addition of the color reagent (15 mg of 4-chloro-1-naphthol in 5 ml of methanol combined with 25 ml of PBS containing 0.06% hydrogen peroxide).
Electron microscopy. A sample of the GroEL-like protein was applied to a carbon-coated collodion-covered grid for 30 s and then negatively stained with 1% aqueous uranyl acetate. Preparations were examined in a Philips EM420 electron microscope operating at 80 kV. Micrographs at nominal magnifications of x36,000 and x60,000 were recorded on Kodak emulsion SO-163.
Image processing. Fields of GroEL-like particles selected for image processing were digitized by using a Perkin-Elmer 1010 MG scanning microdensitometer at a sampling rate corresponding to 0.34 nm/pixel. Images were processed by using the PIC system of programs (36) .
Particles were selected from the digitized fields into 40 by 40 pixel windows and centered by using a rotationally symmetrized reference. The images were then converted to polar coordinates, and the rotational power spectrum was calculated. Particles showing clear sevenfold rotational symmetry were averaged after translational and rotational correlation alignment.
Protein determination. Protein concentration was determined by either the BCA protein assay method (Pierce Chemical Co., Rockford, Ill.) or the method of Lowry et al. (29) , using bovine serum albumin as the standard, or by the method of Bradford (5) represents approximately 2% of the total cytoplasmic protein of B. pertussis, was purified from both Tohama I, a virulent strain, and the avirulent strain 10901. The purity of the preparation from Tohama I was determined by SDS-PAGE and densitometry to be 91%. The purity of the preparation from the avirulent strain was determined to be 98%. An SDS gel showing the protein obtained from Tohama I at various stages of the purification process is shown in Fig.   1 .
While the subunit molecular mass of this protein is 63 kDa (Fig. 1) , the native molecular weight as determined by molecular sieve chromatography was found to be greater than 660,000 (data not shown). The subunit structure of the protein was therefore examined by electron microscopy. Two distinct views of the particles are evident (Fig. 2 ). An end-on projection view looking down the particle axis exhibits a sevenfold symmetry. The diameter of the molecule is 15
nm. The side view shows a rectangular-shaped particle with four equally spaced transverse stain-excluding striations similar to those seen in electron micrographs of GroEL (22) . Occasionally particles in side view can be seen attached to each other along the particle axis. The similar structures of this molecule and GroEL, which is a tetradecamer (22) (2) which is a member of the GroEL family of proteins. We have found that the B. pertussis protein also binds to polyclonal antibodies which were elicited by the chlamydial member of the GroEL family (Fig. 3) . Moreover, polyclonal antibodies raised against the purified B. pertussis protein react with a protein found in E. coli extracts (Fig. 3) . This E. coli protein is likely GroEL since it has the expected molecular size and since antibodies to the mycobacterial GroEL-like protein also react with a protein of identical molecular size. It should be noted that in this experiment, the monoclonal antibody raised to the mycobacterial GroEL-like protein also reacted with an additional protein (Mr = 40,000). While the identity of this protein is not known, it may represent a breakdown product of GroEL.
Previously, antibodies to this B. pertussis protein were found in sera from children immunized with DTP vaccine (2) . Since the possibility existed that these antibodies were not elicited by the DTP vaccine but rather by bacteria other than B. pertussis to which the children were exposed, we immunized mice with a DTP vaccine. A standard DTP vaccine was used which contained diphtheria and tetanus toxoids as well as killed, whole B. pertussis cells. While normal mouse serum did not contain antibodies to the B. Fig. 4 . The identities of these aised to the M. proteins are unknown but may represent contaminating ,lonal antiserum proteins in the preparation which are reactive with antibodike protein (lane ies in the various sera. Alternatively, these proteins may be kilodaltons) are degradation products of the GroEL-like protein.
Since the GroEL-like protein antigen is present in a DTP vaccine and since it can elicit an antibody response, we examined the ability of this protein to protect mice against ed with DTP aerosol challenge with B. pertussis. In each of two experie B. pertussis ments, the majority of mice which had been immunized with lysis (Fig. 4) .
the GroEL-like protein from B. pertussis did not survive past milar to those 21 days postchallenge (Table 1 ). In contrast, most of the mice immunized with pertussis toxoid survived. GroEL-like proteins are not only found in bacteria but are present in chloroplasts of plants and mitochondria of eucaryotes. The mitochondrial protein has been named P1 (12 The Bordetella protein described in this study exhibits both immunological and structural similarities to the GroEL family of proteins. This protein has a sevenfold symmetry identical to that described for GroEL and, like GroEL, appears to be a tetradecamer (22) . Recently, a similar molecule was described from Neurospora crassa mitochondria (24) . The size of the Bordetella protein is 15 nm which is close to that measured for N. crassa and is slightly larger than GroEL from E. coli.
GroEL-like proteins are immunodominant antigens from a number of infectious agents including M. leprae, M. tuberculosis, Coxiella burnetti, and Legionella pneumophila (7) . While these proteins can be major immunogens, as indicated by the finding that 10 to 20% of all T cells which respond to M. tuberculosis are specific for the 65-kDa GroEL-like protein (26) , the role that these antigens play in protection (12) . Because of the structural similarity of bacterial GroEL-like proteins and mammalian proteins, these proteins have been proposed to play a role in autoimmunity (10, 12, 25) . Our results suggest that the Bordetella GroEL-like protein and mammalian mitochondrial P1 contain certain similar epitopes. At the present time, we do not know whether the presence of this protein in DTP vaccines has deleterious effects.
The GroEL-like protein of M. tuberculosis appears to play a role in induction of an autoimmune condition in rats known as adjuvant arthritis (10, 25) which is similar to rheumatoid arthritis in humans. The levels of certain antibodies to the 65-kDa mycobacterial protein have been reported to be elevated in rheumatoid arthritis patients (37) . However, active immunization with the mycobacterial GroEL-like protein not only fails to induce adjuvant arthritis but also causes resistance to subsequent induction of arthritis (3, 38) . The epitope on the mycobacterial protein which is responsible for induction of autoimmunity has been mapped to amino acids 180 to 188 of the molecule (38) . At the present time, we do not know whether the Bordetella protein contains an identical epitope. Rheumatoid arthritis has not been classically associated with either DTP vaccination or the disease pertussis.
Millions of doses of DTP vaccine are given to children each year in the United States. At the present time, the risks of the presence of GroEL-like proteins in vaccines remain unknown. Development and use of acellular pertussis vaccines which do not contain the Bordetella GroEL-like protein would circumvent any potential problems that the presence of this immunogenic protein might cause.
